Grifols completes development of molecular test to detect SARS-CoV-2 virus
Catalan Economy
06 May 2020
“Having sufficient molecular test capacity is critical to helping control this pandemic, and having a high-sensitivity test to handle a possible ‘pooling’ strategy is, without a doubt, a differentiating factor, which could make it feasible,” said Victor Grifols Deu, Grifols co-CEO in the company’s press release.
Grifols began developing its test to detect SARS-CoV-2 the first week of February, through its teams in San Diego, Bilbao and Barcelona.
Source: Grifols
Related News and Success stories.
-
29 Sep 2025
See more Lidl launches €140M logistics platform in Barcelona, its biggest in SpainLidl launches €140M logistics platform in Barcelona, its biggest in Spain
-
22 Sep 2025
See more HIPRA opens new €500M Biotech campus in Catalonia, strengthening Europe’s Life Sciences hubHIPRA opens new €500M Biotech campus in Catalonia, strengthening Europe’s Life Sciences hub
-
18 Sep 2025
See more DHL Express inaugurates new €80M international hub in BarcelonaDHL Express inaugurates new €80M international hub in Barcelona
-
15 Sep 2025
See more Trace ID opens new 2,000 m2 chip welding plant in Barcelona, a European firstTrace ID opens new 2,000 m2 chip welding plant in Barcelona, a European first
